Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Fajardo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2020
Medication use evaluation of the financial and clinical implications of ixazomib compared to bortezomib in the outpatient settingKatelyn A Zink, Susan Fajardo
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Specialty pharmacy for hematologic malignanciesSusan Fajardo, Felicia Zook, Emily Dotson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 12, 2022
Daratumumab infusion reaction rates pre- and post-addition of montelukast to pre-medicationsKelsey Coffman, Coby Carstens, Susan Fajardo
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2020
Medication use evaluation of the financial and clinical implications of ixazomib compared to bortezomib in the outpatient settingKatelyn A Zink, Susan Fajardo
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Specialty pharmacy for hematologic malignanciesSusan Fajardo, Felicia Zook, Emily Dotson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 12, 2022
Daratumumab infusion reaction rates pre- and post-addition of montelukast to pre-medicationsKelsey Coffman, Coby Carstens, Susan Fajardo
Pageof 1